Goyal, M., Chauhan, A., Goyal, V., Jaiswal, N. , Singh, S. and Singh, M. (2018) Recent development in the strategies projected for chikungunya vaccine in humans. Drug Design, Development and Therapy, 12, pp. 4195-4206. (doi: 10.2147/DDDT.S181574) (PMID:30573950) (PMCID:PMC6292406)
Text
239460.pdf - Published Version Available under License Creative Commons Attribution Non-commercial. 610kB |
Abstract
The unprecedented epidemic spread of chikungunya worldwide illustrates the critical need for potent vaccines and therapeutic interventions. The morbidity and mortality associated with this arboviral infection has become a major public health problem in many countries across different continents. Increasing public–private partnerships have opened new avenues in research and development of vaccines. This review mainly focuses on the recent advances in patented approaches for chikungunya vaccine development and the forthcoming challenges.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Jaiswal, Dr Nishant |
Authors: | Goyal, M., Chauhan, A., Goyal, V., Jaiswal, N., Singh, S., and Singh, M. |
College/School: | College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Health Economics and Health Technology Assessment |
Journal Name: | Drug Design, Development and Therapy |
Publisher: | Dove Medical Press |
ISSN: | 1177-8881 |
ISSN (Online): | 1177-8881 |
Published Online: | 10 December 2018 |
Copyright Holders: | Copyright © 2018 Goyal et al. |
First Published: | First published in Drug Design, Development and Therapy 12: 4195-4206 |
Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record